eXoZymes, Inc.
EXOZ
$7.80
-$0.82-9.51%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -20.04% | 21.29% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -11.45% | 6.87% | |||
| Operating Income | 11.45% | -6.87% | |||
| Income Before Tax | 14.13% | -20.69% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 10.73% | -16.09% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 10.73% | -16.09% | |||
| EBIT | 11.45% | -6.87% | |||
| EBITDA | 11.79% | -6.99% | |||
| EPS Basic | 11.41% | -15.99% | |||
| Normalized Basic EPS | 14.79% | -20.60% | |||
| EPS Diluted | 11.41% | -15.99% | |||
| Normalized Diluted EPS | 14.79% | -20.60% | |||
| Average Basic Shares Outstanding | 0.78% | 0.07% | |||
| Average Diluted Shares Outstanding | 0.78% | 0.07% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||